My February 1st tranche has just a few weeks left to run. It has been a struggle - although I guess +16.5% is not bad. VEC and DEPO were both huge winners at one point. VEC was up 60% in August. DEPO was up 60% in September. I came so close to selling some DEPO calls around then, I think I actually placed an order.
PERI is the lead weight. Doing the math, if you have one stock down 30%, it is tough to soar like an eagle. I really liked them at the time. They had just had an acquisition and I felt the market was not valuing it correctly. But they struggled to make money. The "turnaround" has always been a couple quarters away. That being said, PERI has moved up a lot (on % basis) of late. It actually "broke a buck" at the end of October and is now $1.65. So a 65% gain in 3 months. Entry point is everything.
Here is the tranche:
2/1/2016 | Start | Current | Dividend | Pct Gain | R3K Gain |
VEC | $19.64 | $24.05 | $0.00 | 22.5% | 21.3% |
QCOM | $45.18 | $66.10 | $2.07 | 50.9% | 21.3% |
PERI | $2.45 | $1.65 | $0.00 | -32.7% | 21.3% |
DEPO | $15.34 | $18.90 | $0.00 | 23.2% | 21.3% |
TDC | $24.02 | $28.47 | $0.00 | 18.5% | 21.3% |
Totals | 16.5% | 21.3% |
If I had just renewed my February 2015 tranche, I'd be on par with market (up 21%). My rejects are about the same as picks (up 15%). HPQ and BRCD are both up 55%, but LCI, CBI and VIAB are all down around 15%.
Looking Forward
With recent run-up in MFI stocks, I am struggling a bit to find value.
IDCC, LEA, SSNI, AKRX, GHC, WNC, ABBV, MYGN, KLAC and OMC,
A lot can still happen. Stay tuned.
No comments:
Post a Comment